Cargando…
Comparison of baseline lymphoma and HIV characteristics in Malawi before and after implementation of universal antiretroviral therapy
Access to antiretroviral therapy (ART) led to epidemiological changes in human immunodeficiency virus (HIV) associated lymphoma in high-income countries such as reductions in diffuse large B-cell lymphoma (DLBCL) and stable or increased Hodgkin lymphoma (HL) and Burkitt lymphoma (BL). In 2016, Malaw...
Autores principales: | Gondwe, Yolanda, Kudowa, Evaristar, Tomoka, Tamiwe, Kasonkanji, Edwards D., Kaimila, Bongani, Zuze, Takondwa, Mumba, Noel, Kimani, Stephen, Mulenga, Maurice, Chimzimu, Fred, Kampani, Coxcilly, Randall, Cara, Lilly, Amy, Gopal, Satish, Fedoriw, Yuri, Painschab, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436050/ https://www.ncbi.nlm.nih.gov/pubmed/36048901 http://dx.doi.org/10.1371/journal.pone.0273408 |
Ejemplares similares
-
Plasmablastic lymphoma in Malawi
por: Zuze, Takondwa, et al.
Publicado: (2018) -
Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi
por: Painschab, Matthew S., et al.
Publicado: (2022) -
High pretreatment plasma Epstein‐Barr virus (EBV) DNA level is a poor prognostic marker in HIV‐associated, EBV‐negative diffuse large B‐cell lymphoma in Malawi
por: Montgomery, Nathan D., et al.
Publicado: (2019) -
Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial
por: Kimani, Stephen, et al.
Publicado: (2021) -
Modified EPOCH for high‐risk non‐Hodgkin lymphoma in sub‐Saharan Africa
por: Zuze, Takondwa, et al.
Publicado: (2019)